Advertisement

Clinical Approach to Adnexal Disease

  • Sergio Pecorelli
  • Franco Odicino
  • Giancarlo Tisi

Abstract

The diagnostic-instrumental finding of an alteration to the adnexal region occurs in 1.5–2% of females over 40 years of age and poses a complex problem of differential diagnosis. Correct identification of the condition is crucial for the appropriate clinical management of the disease.

Keywords

Ovarian Cancer Bicornuate Uterus Septate Uterus Adenomatoid Tumor Unicornuate Uterus 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Campbell S, Bhan V, Royston P et al (1989) Transabdominal ultrasound screening for early ovarian cancer. BMJ 299:1363–1367CrossRefPubMedGoogle Scholar
  2. Jacobs IJ et al (1990) A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynecol 97:922–29Google Scholar
  3. Schneider VL et al (1993) Comparison of Doppler with two dimensional sonography and CA125 for predictionof malignancy of pelvic masses. Obstet Gynecol 81:983–88PubMedGoogle Scholar
  4. Einhorn N, Bast R, Knapp R et al (2000) Long-term follow up of the Stockholm screening study on ovarian cancer. Gynecol Oncol 79:466–470CrossRefPubMedGoogle Scholar
  5. Jemal A, Siegel R, Ward E et al (2007) Cancer statistics 2007. CA Cancer J Clin 57:43–66CrossRefPubMedGoogle Scholar
  6. Kazerouni N, Greene MH, Lacey JV Jr et al (2006) Family history of breast cancer as a risk factor for ovarian cancer in a prospective study. Cancer 107:1075–1083CrossRefPubMedGoogle Scholar
  7. Markman M (1994) Follow-up of the asymptomatic patient with ovarian cancer. Gynecol Oncol 55:S134–137CrossRefPubMedGoogle Scholar
  8. Pecorelli S, Sartori E, Santin A (1994) Follow-up after primary therapy: management of the symptomatic patient surgery. Gynecol Oncol 55:S138–142CrossRefPubMedGoogle Scholar
  9. Reed NS, Sadozye AH (2005) Role of chemotherapy in the management of epithelial ovarian cancer. Expert Rev Anticancer Ther 5(1):139–147CrossRefPubMedGoogle Scholar
  10. The ICON and AGO Collaborators (2003) Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in women with relapsed ovarian cancer: the ICON 4/AGO_OVAR 2.2 trial. Lancet 1361:2099–2106Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Sergio Pecorelli
    • 1
  • Franco Odicino
    • 1
  • Giancarlo Tisi
    • 1
  1. 1.Department of Gynaecology and ObstetricsUniversity of Brescia A. O. Spedali CiviliBresciaItaly

Personalised recommendations